Literature DB >> 12351684

The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.

Cynthia A Heinlein1, Chawnshang Chang.   

Abstract

The biological activity of testosterone and dihydrotestosterone is thought to occur predominantly through binding to the androgen receptor (AR), a member of the nuclear receptor superfamily that functions as a ligand-activated transcription factor. However, androgens have also been reported to induce the rapid activation of kinase-signaling cascades and modulate intracellular calcium levels. These effects are considered to be nongenomic because they occur in cell types that lack a functional AR, in the presence of inhibitors of transcription and translation, or are observed to occur too rapidly to involve changes in gene transcription. Such nongenomic effects of androgens may occur through AR functioning in the cytoplasm to induce the MAPK signal cascade. In addition, androgens may function through the sex hormone binding globulin receptor and possibly a distinct G protein-coupled receptor to activate second messenger signaling mechanisms. The physiological effect of nongenomic androgen action has yet to be determined. However, it may ultimately contribute to regulation of transcription factor activity, including mediation of the transcriptional activity of AR.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351684     DOI: 10.1210/me.2002-0070

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  146 in total

Review 1.  Membrane steroid receptor-mediated action of soy isoflavones: tip of the iceberg.

Authors:  Vladimir Ajdžanović; Ivana Medigović; Jasmina Živanović; Marija Mojić; Verica Milošević
Journal:  J Membr Biol       Date:  2014-11-02       Impact factor: 1.843

Review 2.  The endocrine pharmacology of testosterone therapy in men.

Authors:  Michael Oettel
Journal:  Naturwissenschaften       Date:  2004-01-28

3.  GPRC6A mediates the non-genomic effects of steroids.

Authors:  Min Pi; Abby L Parrill; L Darryl Quarles
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

4.  Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells.

Authors:  Cecilia Colombero; Daniela Papademetrio; Paula Sacca; Eduardo Mormandi; Elida Alvarez; Susana Nowicki
Journal:  Horm Cancer       Date:  2017-06-21       Impact factor: 3.869

5.  Dihydrotestosterone stimulates aldosterone secretion by H295R human adrenocortical cells.

Authors:  Licy L Yanes; Damian G Romero
Journal:  Mol Cell Endocrinol       Date:  2009-01-21       Impact factor: 4.102

6.  Androgens in health and disease: an overview.

Authors:  Cynthia L Jordan; Lydia Doncarlos
Journal:  Horm Behav       Date:  2008-03-06       Impact factor: 3.587

7.  Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres.

Authors:  M M Hamdi; G Mutungi
Journal:  J Physiol       Date:  2009-12-14       Impact factor: 5.182

8.  Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226.

Authors:  Feng Wang; Xiao-qin Liu; He Li; Kai-ni Liang; Jeffrey N Miner; Mei Hong; E Adam Kallel; Arjan van Oeveren; Lin Zhi; Tao Jiang
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-25

Review 9.  Androgen receptor and growth factor signaling cross-talk in prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  Endocr Relat Cancer       Date:  2008-07-30       Impact factor: 5.678

10.  Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells.

Authors:  Meng-Lei Zhu; Natasha Kyprianou
Journal:  FASEB J       Date:  2009-11-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.